Lyell Immunopharma, Inc. (LYEL) — Institutional Ownership     Insider Trades

Lyell Immunopharma, Inc. (LYEL) — among the top institutional holders, 24 hedge funds and asset managers reported positions as of Q22026. In Q22026, 9 funds opened a new position, 6 increased their stake, and 4 reduced their holdings. The largest holder is Glaxosmithkline PLC with 1.51M shares valued at $ 21.25M.